FDA.reportPublic FDA data

setmelanotide 10 MG/ML Injectable Solution

RxCUI
2469346
RxNorm name
setmelanotide 10 MG/ML Injectable Solution
Display name
setmelanotide 10 MG/ML Injectable Solution
Full name
setmelanotide 10 MG/ML Injectable Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ImcivreeSETMELANOTIDERhythm Pharmaceuticals, Inc70c3ccf7-4df0-4c75-ba07-fede9970c8d92026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 2469346

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
70c3ccf7-4df0-4c75-ba07-fede9970c8d9setmelanotide 10 MG/ML Injectable Solution [PSN] · setmelanotide 10 MG/ML Injectable Solution [SCD] · setmelanotide 10 MG/ML (as setmelanotide acetate) Injectable Solution [SY]314These highlights do not include all the information needed to use IMCIVREE safely and effectively. See full prescribing information for IMCIVREE. IMCIVREE® (setmelanotide) injection, for subcutaneous use Initial U.S. Approval: 202020260401